MPLT logo

MPLTMapLight Therapeutics Inc.

$30.35
$2.55
(9.17%)
Today
Closed $30.35
$0.00
(0.00%)
After Hours
Updated: 06:28 PM EDT
Reported EarningsMay 14
Mkt Cap$1.18B
Vol255,463.00
News
all
press releases
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Upgraded by HC Wainwright
HC Wainwright raised shares of Maplight Therapeutics to a "strong-buy" rating in a research report on Monday...
MarketBeat
News Placeholder
More News
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Shares Down 5.5% - Here's What Happened
Maplight Therapeutics (NASDAQ:MPLT) Shares Down 5.5% - Here's What Happened...
MarketBeat
News Placeholder
Jonathan Gillis Sells 51,900 Shares of Maplight Therapeutics (NASDAQ:MPLT) Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Jonathan Gillis sold 51,900 shares of Maplight Therapeutics stock in a transaction on Monday, April 27th. The stock was sold at an...
MarketBeat
News Placeholder
Anatol Kreitzer Sells 45,422 Shares of Maplight Therapeutics (NASDAQ:MPLT) Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Anatol Kreitzer sold 45,422 shares of the company's stock in a transaction that occurred on Monday, April 27th. The stock was sold...
MarketBeat
News Placeholder
Insider Selling: Maplight Therapeutics (NASDAQ:MPLT) Insider Sells 17,935 Shares of Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Jonathan Gillis sold 17,935 shares of the company's stock in a transaction dated Tuesday, April 28th. The shares were sold at an...
MarketBeat
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Hits New 52-Week High - What's Next?
Maplight Therapeutics (NASDAQ:MPLT) Reaches New 52-Week High - Should You Buy...
MarketBeat
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 12.8% - Still a Buy?
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 12.8% - Here's Why...
MarketBeat
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Down - Here's Why
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Down - Here's Why...
MarketBeat
News Placeholder
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the nine ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommenda...
MarketBeat
News Placeholder
Maplight Therapeutics, Inc.'s (NASDAQ:MPLT) Lock-Up Period To Expire on April 27th
Maplight Therapeutics' (NASDAQ:MPLT - Get Free Report) lock-up period is set to end on Monday, April 27th. Maplight Therapeutics had issued 14,750,000 shares in its IPO on October 27th. The total...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.